Safety and clinical activity of adenosine A2a receptor (A2aR) antagonist, CPI-444, in anti-PD1/PDL1 treatment-refractory renal cell (RCC) and non-small cell lung cancer (NSCLC) patients
Fong, Lawrence, Forde, Patrick M., Powderly, John D., Goldman, Jonathan Wade, Nemunaitis, John J., Luke, Jason John, Hellmann, Matthew David, Kummar, Shivaani, Doebele, Robert Charles, Mahadevan, Daruka, Gadgeel, Shirish M., Hughes, Brett Gordon Maxwell, Markman, Ben, Riese, Matthew John, Brody, Joshua, Emens, Leisha A., McCaffery, Ian, Miller, Richard Alan, Laport, Ginna
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Liver-directed therapy (LDT) for metastatic renal cell carcinoma (mRCC): Single center experience
Raychaudhuri, Ruben, Bylow, Kathryn A., Lea, William, Byun, John, Zellmer, Timothy, Burfeind, John D., Riese, Matthew John, Kilari, Deepak
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
Epacadostat plus nivolumab for advanced melanoma: Updated phase 2 results of the ECHO-204 study
Daud, Adil, Saleh, Mansoor N., Hu, James, Bleeker, Jonathan Scott, Riese, Matthew John, Meier, Roland, Zhou, Li, Serbest, Gul, Lewis, Karl D.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Effect of β-hydroxy-β-methylbutyrate (HMB) on muscle strength in older men with prostate cancer (Pca) started on androgen deprivation therapy (ADT): Preliminary results of an open-label, randomized trial
Bylow, Kathryn A., Kilari, Deepak, Riese, Matthew John, Burfeind, John, Stolley, Melinda, Prost, Robert W, Musto, Kaylinn, Neilson, Raquel, Szabo, Aniko, Thomas, James P., Ng, Alexander V.
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
Emerging clinical phenotype of bone metastatic urothelial cancer (mUC): Association of early osseous metastases (EOM) and outcomes
Nelson, Ariel Ann, Cronk, Robert, Szabo, Aniko, Lemke, Emily, Giever, Thomas A., Burfeind, John D., Kilari, Deepak, Riese, Matthew John, Bylow, Kathryn A., Diamantopoulos, Leonidas Nikolaos, Khaki, Ali Raza, Nezami, Behtash, MacLennan, Gregory, Draves, Mary Ann, Goolamier, Gordon, Rosey, Samantha, Calaway, Adam, Grivas, Petros, Ponsky, Lee Evan, Hoimes, Christopher J.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Epacadostat plus nivolumab in patients with advanced solid tumors: Preliminary phase I/II results of ECHO-204
Perez, Raymond P., Riese, Matthew John, Lewis, Karl D., Saleh, Mansoor N., Daud, Adil, Berlin, Jordan, Lee, James J., Mukhopadhyay, Sutapa, Zhou, Li, Serbest, Gul, Hamid, Omid
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
PROPEL: A phase 1/2 trial of NKTR-214 (CD122-biased agonist) combined with anti-PD-1 (pembrolizumab) or anti-PD-L1 (atezolizumab) in patients (pts) with advanced solid tumors
Vaena, Daniel A., Chaves, Jorge, Vogelzang, Nicholas J., Matrana, Marc Ryan, Gabayan, A. Eli, Riese, Matthew John, Cho, Daniel C., Tagliaferri, Mary Ann, Zalevsky, Jonathan, Xie, Sunny, Hoch, Ute, RIZWAN, AHSAN NAQI, Aung, Sandra, Imperiale, Michael, Schwarz, James K.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article